<--- Back to Details
First PageDocument Content
Factor VIII / Octapharma / Coagulation / Von Willebrand disease / Factor VII / Thrombin / Haemophilia / Recombinant DNA / Factor V / Coagulation system / Blood / Anatomy
Date: 2010-09-08 05:47:02
Factor VIII
Octapharma
Coagulation
Von Willebrand disease
Factor VII
Thrombin
Haemophilia
Recombinant DNA
Factor V
Coagulation system
Blood
Anatomy

Microsoft Word - Full Report Coagulation Factors September 2010

Add to Reading List

Source URL: www.pipelinereview.com

Download Document from Source Website

File Size: 59,12 KB

Share Document on Facebook

Similar Documents

News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1q38M - View Document

News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1pMmB - View Document

13307 FT Factor VII plasma deficient

13307 FT Factor VII plasma deficient

DocID: 1mVEV - View Document

UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows  Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A •

UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A •

DocID: 1kAcN - View Document